BUSINESS● LOW2h ago · Sep 23, 2026, 10:18 AM

BoomRay and Novartis Pharma sign $900m deal for radioligand therapy

Yahoo Finance · global

BoomRay and Novartis Pharma have signed a $900 million deal concerning radioligand therapy. This represents a significant business transaction in the pharmaceutical industry.

Read at Yahoo Finance Ask the Analyst about this

GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.

See it on the live mapEvents around the world right now

More in Business

BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSEC BUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSEC BUSINESS8m agoDRC: Baraka Kabemba, the consultant who wants to boost Gécamines' revenuesJeune Afrique BUSINESS33m agoSolana ETF declares monthly distribution of $0.0194Seeking Alpha Tech